Molecular mechanisms of drug resistance in ovarian cancer

被引：187

作者：

Norouzi-Barough, Leyla ^{[1
]}

Sarookhani, Mohammad Reza ^{[2
]}

Sharifi, Mohammadreza ^{[3
]}

Moghbelinejad, Sahar ^{[4
]}

Jangjoo, Saranaz ^{[5
]}

Salehi, Rasoul ^{[3
]}

机构：

[1] Qazvin Univ Med Sci, Sch Med, Dept Mol Med, Qazvin, Iran

[2] Qazvin Univ Med Sci, Cellular & Mol Res Ctr, Qazvin, Iran

[3] Isfahan Univ Med Sci, Sch Med, Dept Genet & Mol Biol, Esfahan 81744176, Iran

[4] Qazvin Univ Med Sci, Sch Med, Dept Biochem & Genet, Qazvin, Iran

[5] Shiraz Univ Med Sci, Sch Med, Shiraz, Iran

来源：

JOURNAL OF CELLULAR PHYSIOLOGY | 2018年 / 233卷 / 06期

关键词：

chemotherapeutic agents; drug resistance; molecular mechanisms; ovarian cancer; LONG NONCODING RNA; GLUTATHIONE-S-TRANSFERASE; EPITHELIAL-MESENCHYMAL-TRANSITION; OXYGEN SPECIES ROS; CISPLATIN RESISTANCE; CHEMOTHERAPY RESISTANCE; MULTIDRUG-RESISTANCE; ABC TRANSPORTERS; OXIDATIVE STRESS; MDR1/P-GLYCOPROTEIN EXPRESSION;

D O I：

10.1002/jcp.26289

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Ovarian cancer is the most lethal malignancy among the gynecological cancers, with a 5-year survival rate, mainly due to being diagnosed at advanced stages, recurrence and resistance to the current chemotherapeutic agents. Drug resistance is a complex phenomenon and the number of known involved genes and cross-talks between signaling pathways in this process is growing rapidly. Thus, discovering and understanding the underlying molecular mechanisms involved in chemo-resistance are crucial for management of treatment and identifying novel and effective drug targets as well as drug discovery to improve therapeutic outcomes. In this review, the major and recently identified molecular mechanisms of drug resistance in ovarian cancer from relevant literature have been investigated. In the final section of the paper, new approaches for studying detailed mechanisms of chemo-resistance have been briefly discussed.

引用

页码：4546 / 4562

页数：17

共 50 条

[1] Molecular mechanisms of cisplatin resistance in ovarian cancer
Jiang, Chenying
Shen, Chenjun
Ni, Maowei
Huang, Lili
Hu, Hongtao
Dai, Qinhui
Zhao, Huajun
Zhu, Zhihui
GENES & DISEASES, 2024, 11 (06)
[2] MECHANISMS OF DRUG-RESISTANCE IN OVARIAN-CANCER
JOHNSON, SW
OZOLS, RF
HAMILTON, TC
CANCER, 1993, 71 (02) : 644 - 649
[3] Molecular mechanisms of drug resistance in renal cancer
Szenajch, Jolanta
Cieslak, Agata
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2005, 9 (03): : 123 - 128
[4] Molecular mechanisms of drug resistance in lung cancer
Veslemes, M
2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 465 - 469
[5] Molecular mechanisms of magnolin resistance in ovarian cancer cells
Yoo, Sun-Mi
Lee, Cheol-Jung
Kim, Seung-Min
Cho, Seon-Yeon
Park, Juhee
Cho, Yong-Yeon
CANCER RESEARCH, 2018, 78 (13)
[6] Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options
Nunes, Mariana
Bartosch, Carla
Abreu, Miguel Henriques
Richardson, Alan
Almeida, Raquel
Ricardo, Sara
CELLS, 2024, 13 (09)
[7] Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Alatise, Kharimat Lora
Gardner, Samantha
Alexander-Bryant, Angela
CANCERS, 2022, 14 (24)
[8] Molecular mechanisms of drug resistance and its reversal in cancer
Kartal-Yandim, Melis
Adan-Gokbulut, Aysun
Baran, Yusuf
CRITICAL REVIEWS IN BIOTECHNOLOGY, 2016, 36 (04) : 716 - +
[9] Molecular and Physiologic Mechanisms of Drug Resistance in Cancer: An Overview
R.S. Kerbel
Cancer and Metastasis Reviews, 2001, 20 : 1 - 2
[10] Molecular and physiologic mechanisms of drug resistance in cancer: An overview
Kerbel, RS
CANCER AND METASTASIS REVIEWS, 2001, 20 (1-2) : 1 - 2

← 1 2 3 4 5 →